Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Washington Prime Group Inc

Start price
Target price
Perf. (%)
€0.54
€0.40
-

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Inovio Pharma

Start price
Target price
Perf. (%)
€13.60
-
3.677%

Risky Investment
Orange S.A.

Start price
Target price
Perf. (%)
€9.30
€15.00
-1.333%

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Small cyclical dependencies
Evotec AG

Start price
Target price
Perf. (%)
€23.43
-
-2.732%

Tesla Inc

Start price
Target price
Perf. (%)
€346.25
-
-4.679%

Very capable Management
AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
€78.00
2.213%

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
-
1.010%

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gogold Resources Inc.

Start price
Target price
Perf. (%)
€0.95
-
-1.889%

Could be very worthwhile Investment >20% year
Chalice Gold Mines Ltd

Start price
Target price
Perf. (%)
€1.41
-
6.762%

Could be very worthwhile Investment >20% year
Fiserv Inc.

Start price
Target price
Perf. (%)
€85.20
-
0.599%

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Salesforce.com

Start price
Target price
Perf. (%)
€207.85
-
-0.698%

Could be worthwhile Investment >10% per year
Very capable Management
Market Leader or Top 3
Very Future proof/growth oriented business model
Inpixon

Start price
Target price
Perf. (%)
€0.88
€2.00
0.568%

Could be very worthwhile Investment >20% year
Smith & Wesson Brands Inc.

Start price
Target price
Perf. (%)
€12.61
-
2.982%

AgraFlora Organics International Inc.

Start price
Target price
Perf. (%)
€0.017
-
-11.765%

Some uniques
Higher risks for its business
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.17
€12.00
4.722%

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Tesla Inc

Start price
Target price
Perf. (%)
€377.10
€400.00
-12.477%

Could be worthwhile Investment >10% per year
Capable Management
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.66
-
-2.186%

Revenue decline/stagnation expected
Decining EBIT margin than peer group
High valuation
Very low/no dividend yield expected
Urban One Inc.

Start price
Target price
Perf. (%)
€3.06
-
5.882%

EBIT decline > 20% expected
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
Sol-gel Technologies Ltd.

Start price
Target price
Perf. (%)
€6.20
€8.00
-1.613%

Fair valuation
Eastman Kodak

Start price
Target price
Perf. (%)
€9.95
€7.00
-20.527%

Risky Investment
Significant cyclical dependencies
Business model of the past or high risk
Quantafuel As

Start price
Target price
Perf. (%)
€6.99
-
-12.733%

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
-
35.135%

Risky Investment
Yamana Gold Inc.

Start price
Target price
Perf. (%)
€5.22
-
-9.709%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€29.60
-
-10.710%

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€10.13
-
-15.183%

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation